Higher Doses of Antithymocyte Globulin (ATG) Increase the Risk of Relapse in Acute Myeloid Leukemia (AML) Patients Undergoing Matched Related Donor Allogeneic Transplantation in First Complete Remission (CR1): An Analysis From the Acute Leukemia Working Party of EBMT
Blood - United States
doi 10.1182/blood.v124.21.729.729
Full Text
Open PDFAbstract
Available in full text
Date
December 6, 2014
Authors
Publisher
American Society of Hematology